908 Devices Inc. (MASS)
NASDAQ (NMS) NASDAQ (NMS) Primary 
908 Devices (MASS) Upgraded to Buy: Here's Why
908 Devices (MASS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
908 Devices Looking Better Now (Rating Upgrade)
908 Devices (MASS) delivered strong Q1 results, raising full-year revenue guidance after a strategic acquisition in narcotics detection. Adjusted gross margins improved nearly three percentage points to 57%, and operating cash flow turned positive. The company has a solid balance sheet with nearly $100 million in cash post-acquisition and is debt free, while trading at a reasonable valuation.
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.22 per share a year ago.
'MASS DOMESTIC SURVEILLANCE': Anthropic comes under Pentagon fire, official warns of 'spying'
Anthropic National Security Council member Josh Hodges reacted to the Trump administration's labeling of Claude during an appearance on “Mornings with Maria,” defending the technology and outlining the company's stance on safety, oversight, and secure integration with government systems. 00:00 Pentagon's AI Dilemma with Anthropic 08:01:49 Anthropic's Stance: Human Oversight & Surveillance Fears 08:04:31 LIVE Pentagon Briefing by Secretary Pete Hegseth [ASIDE] 08:09:09 AI Guardrails: Machine vs.
908 Devices Inc. (MASS) Q4 2025 Earnings Call Transcript
908 Devices Inc. (MASS) Q4 2025 Earnings Call Transcript
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.32 per share a year ago.
908 Devices (MASS) Moves 19.2% Higher: Will This Strength Last?
908 Devices (MASS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
908 Devices Inc. (MASS) Q3 2025 Earnings Call Transcript
908 Devices Inc. ( MASS ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Barbara Russo - VP of Marketing & Corporate Communications Kevin Knopp - Co-Founder, CEO, President & Director Joseph Griffith - CFO & Treasurer Conference Call Participants Puneet Souda - Leerink Partners LLC, Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Brendan Smith - TD Cowen, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Ladies and gentlemen, thank you for joining us, and welcome to the 908 Devices Third Quarter 2025 Financial Results Conference Call.
Will 908 Devices Inc. (MASS) Report Negative Earnings Next Week? What You Should Know
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
908 Devices (MASS) Surges 7.0%: Is This an Indication of Further Gains?
908 Devices (MASS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
908 Devices Inc. (MASS) Q2 2025 Earnings Call Transcript
908 Devices Inc. (NASDAQ:MASS ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Joseph H. Griffith - CFO & Treasurer Kevin J.
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.32 per share a year ago.
